RPID SEC Filings - Rapid Micro Biosystems, Inc. 10-K, 10-Q, 8-K Forms

NodeGuardian · 2026-04-11T18:48:07+00:00

The page reviews Rapid Micro Biosystems' SEC filings, including annual and quarterly reports, insider trading activities, and equity compensation grants. It also notes Endeavour Medtech's 5.7% ownership stake in RPID.

NodeGuardian

2026-04-11 18:48:07

Abstract generation in progress

This page provides a comprehensive overview of Rapid Micro Biosystems (RPID) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material events. It details recent insider trading activities, such as automatic sales to cover tax obligations from RSU vesting, and recent equity compensation grants to executives. The page also highlights an ownership disclosure from Endeavour Medtech, showing a 5.7% stake in RPID.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes